Kewaunee Scientific (KEQU) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Kewaunee Scientific Corporation  (NASDAQ: KEQU)
 

Kewaunee Scientific Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Kewaunee Scientific Corporation inventory turnover ratio, the Kewaunee Scientific Corporation's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 6.12 in the first quarter 2026, yet the ratio remained below the average, as KEQU's market remain challenging.Average inventory processing period, for the Kewaunee Scientific in Jul 31 2026 quarter, has decreased to 60 days, compare to 61 days, in the Apr 30 2026 quarter.

Within Healthcare sector 68 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 511 in the fourth quarter 2026, to 739.

KEQU Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Kewaunee Scientific Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KEQU Inventory Turnover Ratio (Jul 31 2026)
I. Quarter		 (Apr 30 2026)
IV. Quarter		 (Jan 31 2026)
III. Quarter		 (Oct 31 2025)
II. Quarter		 (Jul 31 2025)
I. Quarter
Y / Y Inventory Growth -14.71 % -7.05 % 4.27 % 90.25 % 81.09 %
Y / Y Cost of Sales Growth -6.64 % -8.81 % 4.17 % 51.52 % 42.86 %
Inventory Turnover Ratio (TTM) 6.12 5.98 6.02 6.02 6.31
KEQU's Total Ranking # 739 # 511 # 511 # 565 # 518
Average inventory processing period 60 61 61 61 58
Seq. Inventory Growth -2.45 % -7.21 % -7.3 % 1.65 % 6.31 %
Seq. Cost of Sales Growth -6.93 % 0.31 % 0 % 0 % -9.09 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 69
Overall Market # 739

Inventory Turnover Ratio Statistics
High Average Low
8.23 7.24 5.38
(Jul 31 2018)   (Jul 31 2012)



KEQU Company Profile >> Back to KEQU Efficiency Comparisons >> Compare KEQU Inventory Turnover Ratio to its Competitors

Financial Statements
Kewaunee Scientific's Inventories $ 30 Millions Visit KEQU's Balance sheet
Kewaunee Scientific's Cost of Revenues TTM $ 197 Millions Visit KEQU's Income Statement
What are KEQU's Sales? Visit KEQU's Sales by Segment

Other Inventory Turnover Ratios
Kewaunee Scientific's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
KEQU's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for KEQU's Competitors
Inventory Turnover Ratio for KEQU's Suppliers
Inventory Turnover Ratio for KEQU's Customers

You may also want to know
KEQU's Sales Growth Rates KEQU's Pe Price to earnings ratio KEQU's Receivables Turnover Ratio KEQU's Stock Quote
KEQU's Net Income Growth Rates KEQU's Ps Price to Sales ratio KEQU's Sales per Employee KEQU's Asset Turnover Ratio
KEQU's Net Margin KEQU's Pb Price to Book ratio KEQU's Financial Strength Ratios KEQU's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jul 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jul 31 2026 Inventories at quarter ending Jul 31 2026
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Celularity Inc   13.93 $ 15.077  Millions$ 1  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Option Care Health Inc   10.83 $ 4,607.869  Millions$ 426  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Zevra Therapeutics Inc   9.09 $ 17.880  Millions$ 2  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions

Date modified: 2026-09-12T18:36:58+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.